Patent Yard Sign in
Expired Canadian patentCanada

Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation

CA 2538697 C · Owner: Teva Sante · Inventors: Prat, Laurence; Duret, Gerard; Rebiere, Francois

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form, comprising the steps of : a) contacting a pro-chiral sulphide of formula (II) with a metal chiral complex, a base and an oxidizing agent in an organic solvent ; and optionally b) isolating the obtained sulphoxide of formula (I) wherein n, Y, R1, R1a, R2 and R2a are as defined in claim 1.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 17, 2004 and granted November 13, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 17, 2024.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 17, 2026.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 17, 2004
GrantedNovember 13, 2012
Term endedSeptember 17, 2024
Patent numberCA 2538697 C
Classification (IPC)C07C315/02 +1 more

Timeline

Timeline From CIPO dates

2005200720092011201320152017201920212023Application filedSep 17, 2004Patent grantedNov 13, 2012Term endedSep 17, 2024

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.